Related Experiment Videos
Mutant p53--the commonest genetic abnormality in human cancer?
The Journal of Pathology
|September 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
Cancer research·2001
The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research·2000
Fibroblast heterogeneity in Peutz-Jeghers syndrome: identifying the polyp-driving subset†.
The Journal of pathology·2026
SRF fusion genes in myoid soft tissue tumors.
The Journal of pathology·2026
Pancreatic polypeptide interacts with neuropeptide Y4 receptor to promote hepatocellular carcinoma progression.
The Journal of pathology·2026
CCL5 and GLUT1 define leader cells in collective invasion of colorectal cancer.
The Journal of pathology·2026
Optical genome mapping enhanced by refined variant interpretation in pediatric acute lymphoblastic leukemia.
The Journal of pathology·2026
Rare genetic endocrine tumor syndromes: VHL, NF1, TSC, and Carney complex.
Best practice & research. Clinical endocrinology & metabolism·2026